[go: up one dir, main page]

AU2001272750A1 - Tumor-specific promoters - Google Patents

Tumor-specific promoters

Info

Publication number
AU2001272750A1
AU2001272750A1 AU2001272750A AU7275001A AU2001272750A1 AU 2001272750 A1 AU2001272750 A1 AU 2001272750A1 AU 2001272750 A AU2001272750 A AU 2001272750A AU 7275001 A AU7275001 A AU 7275001A AU 2001272750 A1 AU2001272750 A1 AU 2001272750A1
Authority
AU
Australia
Prior art keywords
tumor
specific promoters
promoters
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272750A
Inventor
Masatoshi Tagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PRIMMUNE Corp
Chiba Prefectural Government
Original Assignee
PRIMMUNE CORP
Chiba Prefectural Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PRIMMUNE CORP, Chiba Prefectural Government filed Critical PRIMMUNE CORP
Publication of AU2001272750A1 publication Critical patent/AU2001272750A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001272750A 2000-07-21 2001-07-18 Tumor-specific promoters Abandoned AU2001272750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-220504 2000-07-21
JP2000220504 2000-07-21
PCT/JP2001/006228 WO2002010368A1 (en) 2000-07-21 2001-07-18 Tumor-specific promoters

Publications (1)

Publication Number Publication Date
AU2001272750A1 true AU2001272750A1 (en) 2002-02-13

Family

ID=18715104

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272750A Abandoned AU2001272750A1 (en) 2000-07-21 2001-07-18 Tumor-specific promoters

Country Status (6)

Country Link
US (2) US7030099B2 (en)
EP (2) EP1762614A3 (en)
JP (1) JP4845327B2 (en)
CN (1) CN1252260C (en)
AU (1) AU2001272750A1 (en)
WO (1) WO2002010368A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
AU2003222427B8 (en) 2000-11-17 2010-04-29 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same
AU2002307793B2 (en) 2001-10-19 2007-01-25 Vascular Biogenics Ltd. Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
US6856125B2 (en) * 2001-12-12 2005-02-15 Lifescan, Inc. Biosensor apparatus and method with sample type and volume detection
EP1681988B1 (en) * 2003-11-12 2015-04-08 The Children's Hospital Medical Center Method for diagnosis and treatment of pulmonary disorders
US7063947B2 (en) * 2004-04-08 2006-06-20 Promogen, Inc. System for producing synthetic promoters
RU2499599C2 (en) 2007-09-28 2013-11-27 Интрексон Корпорейшн Therapeutic gene switching constructs and bioreactors for expressing biotherapeutic molecules and using them
CN101649319B (en) * 2009-09-09 2011-11-30 陕西师范大学 Tumor distinctive embedment promoter, constructing method and application thereof
US9018182B2 (en) * 2010-04-26 2015-04-28 Green Cross Corporation Tumor specific promoter and oncolytic virus vector comprising the same
CN108410872A (en) 2011-01-07 2018-08-17 应用遗传科技公司 Promoter, expression cassette, carrier, medicine box and method for treating colour blindness and Other diseases
RU2476596C1 (en) * 2012-02-02 2013-02-27 Общество С Ограниченной Ответственностью "Ива" Multi-purpose promoter, expression vector, and method of selective killing cancer cells with their use
WO2014181314A1 (en) 2013-05-10 2014-11-13 Department Of Biotechnology Placental like alkaline phosphatase (plap) promoter mediated cell targeting
WO2019089755A1 (en) 2017-10-31 2019-05-09 Western Oncolytics Ltd. Platform oncolytic vector for systemic delivery
AU2019212840B2 (en) 2018-01-26 2024-08-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Expression of metabolic modulators in tumor microenvironment to improve tumor therapy
KR20230110545A (en) 2020-11-19 2023-07-24 칼리버 임뮤노쎄라퓨틱스, 인크. Oncolytic immunotherapy by remodeling the tumor microenvironment
WO2022206962A1 (en) * 2021-04-02 2022-10-06 深圳艾欣达伟医药科技有限公司 Recombinant oncolytic virus and medical use thereof
IL308018B2 (en) 2021-04-30 2025-04-01 Kalivir Immunotherapeutics Inc Oncolytic viruses for modified mhc expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004196A1 (en) * 1992-08-14 1994-03-03 Imperial Cancer Research Technology Limited Tumour therapy
TW442569B (en) * 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US5518885A (en) * 1994-04-19 1996-05-21 The United States Of America As Represented By The Department Of Health & Human Services ERBB2 promoter binding protein in neoplastic disease
US5728379A (en) * 1994-06-23 1998-03-17 Georgetown University Tumor- or cell-specific herpes simplex virus replication
US5998205A (en) * 1994-11-28 1999-12-07 Genetic Therapy, Inc. Vectors for tissue-specific replication
US6432700B1 (en) * 1997-03-03 2002-08-13 Cell Genesys, Inc. Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
JP2002524525A (en) * 1998-09-11 2002-08-06 カリフォルニア・インスティテュート・オブ・テクノロジー Regulation of oncogene HER / 2neu expression by synthetic polyamide
WO2000017339A1 (en) * 1998-09-18 2000-03-30 Kyowa Hakko Kogyo Co., Ltd. Method for the diagnosis of cell proliferative disease

Also Published As

Publication number Publication date
WO2002010368A1 (en) 2002-02-07
US7030099B2 (en) 2006-04-18
EP1762614A2 (en) 2007-03-14
EP1762614A3 (en) 2007-05-30
CN1443238A (en) 2003-09-17
JP4845327B2 (en) 2011-12-28
EP1302539A4 (en) 2004-10-27
US20060099188A1 (en) 2006-05-11
US20030157065A1 (en) 2003-08-21
CN1252260C (en) 2006-04-19
EP1302539A1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2001291151A1 (en) N-acylsulfonamide apoptosis promoters
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2002211620A1 (en) Autoanastomosis
AU2001254546A1 (en) Aminopiperidines
AU2001220246A1 (en) Neckphone
AU2001296577A1 (en) Chlorophyllases
AU2001258349A1 (en) Bisacylguanidine
AU2001272750A1 (en) Tumor-specific promoters
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001258924A1 (en) Microsatellite-aflp
AU2001277581A1 (en) Myocardium-specific promoter
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001260643A1 (en) Ectocornea extension promoters
AU2002214354A1 (en) Neck-phone
AU2001226668A1 (en) Crankshaft-starter-generator
AU2002216268A1 (en) Elongase promoters
AU2001268716A1 (en) Novel chimeric promoters
AU2001262711A1 (en) Cytoprotectors
AU2001260192A1 (en) Glycinamides
AU2001284173A1 (en) Calycins
AU2001295713A1 (en) Blast-processing